Education
About Us
Working with TipRanks
Follow Us
LAVA Therapeutics (LVTX)
NASDAQ:LVTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 11.98M | $ 6.77M | $ 19.39M | $ 5.35M | $ 3.75M |
| Gross Profit | $ 11.98M | $ 3.29M | $ 19.39M | $ 5.35M | $ -11.95M |
| Operating Income | $ -29.69M | $ -43.25M | $ -34.84M | $ -43.61M | $ -14.67M |
| EBITDA | $ 0.00 | $ -40.42M | $ -30.88M | $ -41.02M | $ -14.65M |
| Net Income | $ -25.11M | $ -41.97M | $ -31.91M | $ -42.35M | $ -15.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 76.58M | $ 95.57M | $ 132.87M | $ 151.01M | $ 19.43M |
| Total Assets | $ 80.83M | $ 101.71M | $ 143.43M | $ 157.87M | $ 25.16M |
| Total Debt | $ 395.00K | $ 6.31M | $ 5.45M | $ 5.52M | $ 5.01M |
| Net Debt | $ -34.62M | $ -37.92M | $ -94.88M | $ -145.50M | $ -14.42M |
| Total Liabilities | $ 53.09M | $ 50.53M | $ 57.38M | $ 23.67M | $ 15.80M |
| Stockholders' Equity | $ 27.75M | $ 51.18M | $ 86.04M | $ 134.19M | $ 9.36M |
| Cash Flow | |||||
| Free Cash Flow | $ -19.57M | $ -39.70M | $ 3.46M | $ -33.34M | $ -13.42M |
| Operating Cash Flow | $ -19.54M | $ -38.97M | $ 4.04M | $ -32.48M | $ -12.77M |
| Investing Cash Flow | $ 12.47M | $ -17.64M | $ 9.35M | $ -49.37M | - |
| Financing Cash Flow | $ -569.00K | $ -571.00K | $ 283.00K | $ 171.37M | $ 24.20M |